Brind.
  1. Lineage Cell Therapeutics made a company announcement from Carlsbad, with Robert W. Baird & Co. hosting a presentation on September 2, 2025.

William Demant Invest provided investment for Lineage Cell Therapeutics' preclinical development on August 26, 2025.

1 report, 1 independent Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

William Demant Invest provided investment for Lineage Cell Therapeutics' preclinical development on August 26, 2025.

Who's involved

What this event is mainly about
William Demant InvestLineage Cell Therapeutics

Keep exploring

Part of

Lineage Cell Therapeutics made a company announcement from Carlsbad, with Robert W. Baird & Co. hosting a presentation on September 2, 2025. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireLineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss Three-year term intended to advance preclinical development of ReSonance Up to $12 mi